# Vaxcyte, Inc.: Form 8-K, filed Feb 2, 2026

- Company: [Vaxcyte, Inc.](/companies/pcvx.md) (CIK 1649094)
- Form: 8-K
- Filed: 2026-02-02
- Accepted by EDGAR: Feb 2, 2026, 16:01 ET
- Period: 2026-01-29
- Accession: 0001193125-26-033578
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1649094/000119312526033578/d54534d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1649094/000119312526033578/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1649094/000119312526033578/d54534d8k.htm

Filed Feb 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-033578. Last ingested by Listed: Nov 12, 2026, 19:43 ET. No prices; not investment advice.